Advanced Therapeutics

Papers
(The H4-Index of Advanced Therapeutics is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Dimeric Cholic Acid Peptide Conjugates Act as Effective Antibiotic Adjuvants against Multidrug Resistance (MDR) Gram‐Negative Bacterial Infections50
Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy43
Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development38
A Functionalized Metal–Organic Framework‐Based Controlled Dual‐Drug Delivery System with Short Hairpin RNA and Simvastatin for Ferroptosis in Colorectal Cancer37
Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression (Adv. Therap. 10/2021)35
Mussel‐Inspired Recombinant Adhesive Protein‐Based Functionalization for Consistent and Effective Antimicrobial Treatment in Chronic Inflammatory Skin Diseases34
Issue Information (Adv. Therap. 4/2024)34
Berplatin: A Conjugate of Berberine and Cisplatin Serving as a Potent Antitumor Agent with Distinctive Tumor Cell Uptake and Minimal Side Effects30
29
28
Masthead (Adv. Therap. 12/2021)24
24
HER2 Expression in Circulating Tumor Cells as Prognostic and Predictive Biomarkers for Anti‐HER2 Therapy in Previously Treated Metastatic Colorectal Cancer23
MicroRNA‐Responsive DNA Dendrimer Acts as a Smart STING Signal Amplifier23
Silk Fibroin‐Based Nanoparticles Blended Fluoridated Hydrogel with Photodynamic Antibacterial for Infected Wound Healing22
Magnetic‐Driven Hydrogel Spiral PVA/Fe3O4 Micromotors for Targeted Photothermal Therapy22
The Implication and Application of Brain Glymphatic System in Multiple Diseases21
Surface Charge and Nanoparticle Chromophore Coupling to Achieve Fast Exciton Quenching and Efficient Charge Separation in Photoacoustic Imaging (PAI) and Photothermal therapy (PTT) (Adv. Therap. 11/2019
Liposome‐Mediated Biomimetic Delivery of PLK3 Inhibitor with NIR II‐Triggered Release Prevents Renal Ischemia‐Reperfusion Injury (Adv. Therap. 12/2022)19
0.11027097702026